Cargando…
Possible synergistic effects of hydroxychloroquine and steroids in COVID-19, time for a nuanced approach. Comment on Arshad et al.
Autor principal: | Wiseman, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405873/ https://www.ncbi.nlm.nih.gov/pubmed/32768694 http://dx.doi.org/10.1016/j.ijid.2020.07.064 |
Ejemplares similares
-
Comment on Arshad et al.: Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19
por: Varisco, Tyler J., et al.
Publicado: (2020) -
Comment to Sands et al. — No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19
por: Hoang, Van Thuan
Publicado: (2021) -
Reply to the comment by Osuka et al.
por: Endo, Akira, et al.
Publicado: (2020) -
A comment on Mokabel et al. (2017)
por: Basu, Saurav
Publicado: (2018) -
Evidence inconclusive - comment on article by Schoenfeld et al
por: Beale, David J.
Publicado: (2016)